Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432614 | 0.88 | S1PR2 (0.43) | S1PR2S1PR4S1PR1S1PR3MMP2 | |
| SCHEMBL5053958 | 0.86 | S1PR2 (0.42) | S1PR2S1PR4S1PR1S1PR3MMP2 | |
| SCHEMBL21383587 | 0.85 | S1PR2 (0.44) | S1PR2S1PR4S1PR1S1PR3TYMS | |
| SCHEMBL7645968 | 0.85 | S1PR2 (0.44) | S1PR2S1PR4S1PR1S1PR3TYMS | |
| SCHEMBL5052645 | 0.85 | S1PR2 (0.44) | S1PR2S1PR4S1PR1S1PR3TYMS | |
| Phosphoric Acid SCHEMBL3769852 | 0.81 | CA12 (0.41) | MMP2TGFBR1MMP1MMP3MMP9 | |
| SCHEMBL19472458 | 0.81 | TLR2 (0.37) | S1PR2S1PR4S1PR1S1PR3TYMS | |
| SCHEMBL112305 | 0.80 | TGFBR1 (0.36) | TGFBR1 | |
| SCHEMBL316224 | 0.79 | TGFBR1 (0.41) | TGFBR1 | |
| SCHEMBL5163038 | 0.79 | ALDH1A1 (0.35) | TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 436 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025260202-A1 | AIR PRINTING OF HYDROGELS | ALLARTA LIFE SCIENCE INC. (CA) | 2025-12-26 | — | — | WO | claimed |
| WO-2025260204-A1 | CROSSLINKED HYDROGELS WITH CONTROLLED PERMEABILITY | ALLARTA LIFE SCIENCE INC. (CA) | 2025-12-26 | — | — | WO | claimed |
| EP-3802510-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | Bostik SA (FR) | 2021-04-14 | — | — | EP | claimed |
| CN-112533910-A | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2021-03-19 | — | — | CN | claimed |
| CN-108348402-B | Polymerizable composition based on thermally cleavable compounds | 义获嘉伟瓦登特公司 | 2021-02-02 | — | — | CN | claimed |
| EP-2578201-B1 | Dental materials with improved hydrolysis stability on the basis of phthalic acid monomers | IVOCLAR VIVADENT AG (LI) | 2020-11-25 | — | — | EP | claimed |
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | IVOCLAR VIVADENT AG (LI) | 2020-06-02 | — | — | US | claimed |
| EP-3156031-B9 | POLYMERISABLE COMPOSITIONS BASED ON THERMALLY CLEAVABLE COMPOUNDS | IVOCLAR VIVADENT AG (LI) | 2020-03-18 | — | — | EP | claimed |
| EP-3004288-B1 | NON-HALOGEN FLAME RETARDANT POLYMERS | LUBRIZOL ADVANCED MAT INC (US) | 2020-02-05 | — | — | EP | claimed |
| CN-110655610-A | Halogen-free flame-retardant polymer | 路博润高级材料公司 | 2020-01-07 | — | — | CN | claimed |
| EP-2578201-A1 | Dental materials with improved hydrolysis stability on the basis of phthalic acid monomers | Ivoclar Vivadent AG (LI) | 2013-04-10 | — | — | EP | claimed |
| WO-2013034777-A2 | DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES | IVOCLAR VIVADENT AG (LI) | 2013-03-14 | — | — | WO | claimed |
| WO-2013034778-A2 | DENTAL MATERIALS BASED ON COMPOUNDS HAVING DEBONDING-ON-DEMAND PROPERTIES | IVOCLAR VIVADENT AG (LI) | 2013-03-14 | — | — | WO | claimed |
| US-8158561-B2 | Scale and corrosion inhibitors for high temperature and pressure conditions | ROHM AND HAAS COMPANY (US) | 2012-04-17 | — | — | US | claimed |
| EP-2298704-A1 | Scale and corrosion inhibitors for high temperature and pressure conditions | Rohm and Haas Company (US) | 2011-03-23 | — | — | EP | claimed |
| US-20110046023-A1 | Scale and corrosion inhibitors for high temperature and pressure conditions | ROHM AND HAAS COMPANY | 2011-02-24 | — | — | US | claimed |
| US-7714034-B2 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | IVOCLAR VIVADENT AG (LI) | 2010-05-11 | — | — | US | claimed |
| EP-1749513-B1 | Photopolymerisable dental material with bisacylphosphine oxides as initiator | IVOCLAR VIVADENT AG (LI) | 2009-03-04 | — | — | EP | claimed |
| EP-1749513-A1 | Photopolymerisable dental material with bisacylphosphine oxides as inhibitors | Ivoclar Vivadent AG (LI) | 2007-02-07 | — | — | EP | claimed |
| US-20070027229-A1 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | IVOCLAR VIVADENT AG (LI) | 2007-02-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | CAD, TERB1, MLX | PGK1 1764/4885PGK2 2470/4885S1PR2 4582/4885 |
| US-20070027229-A1 | Photopolymerizable dental materials with bisacylphosphine oxides as initiators | PRXL2A, PGM2, PAM | PGK1 23/4885PGK2 13/4885S1PR2 1618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.